MedTrace Logo

Cell Samples From Patients With Leukemia

NCT01395628 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2016-05-19

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about cancer and the development of drug resistance in patients. It may also help doctors find better ways to treat cancer.

PURPOSE: This research trial is studying samples from patients with leukemia.

Conditions

Interventions

DRUG

in vitro sensitivity-directed chemotherapy

OTHER

cell proliferation assay

OTHER

fluorescence activated cell sorting

OTHER

laboratory biomarker analysis

OTHER

microscopy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Jason N. Berman, MD · IWK Health Centre

Eligibility

Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01395628 on ClinicalTrials.gov